[1] |
PENG Zishan, KONG Hui, BAO Zhen, ZHAO Hongxing, LIU Xin, LU Shaohua.
Clinicopathological analysis of 83 cases of multifocal lung adenocarcinoma
[J]. China Oncology, 2021, 31(5): 408-418.
|
[2] |
XIAO Feng , XIAO Jingwen , SHAO Jianguo , CHEN Liyan , GU Chunyan .
The expression of programmed death 1 in tumor-infiltrating lymphocytes of hepatocellular carcinoma and its correlation with prognosis
[J]. China Oncology, 2021, 31(5): 419-427.
|
[3] |
NIU Na, LIN Yansong.
Application and research progress of selective internal radiation therapy with 90 Y microspheres in hepatocellular carcinoma
[J]. China Oncology, 2021, 31(5): 428-434.
|
[4] |
LIU Min , CHEN Tianliang , GUO Juan , YI Xue , GAO Hongquan , WU Jiacui , WANG Yuxiao .
Protein kinase Cβ Ⅱ promotes invasion of hepatocellular carcinoma by modulating autocrine of IL-6
[J]. China Oncology, 2021, 31(4): 268-276.
|
[5] |
ZHANG Jun , DONG Yuhua , YANG Ye , ZHANG Mengqi , HE Chang .
A novel strategy of regorafenib in combination with TAS102 against hepatocellular carcinoma
[J]. China Oncology, 2021, 31(4): 294-301.
|
[6] |
ZHAO Yuanyuan , ZHOU Jianying , FAN Yun , WANG Jialei , HUANG Dingzhi , LI Junling , SHI Meiqi , LIU Jiwei , YAO Yu , WU Lin , YAO Wenxiu , ZHANG Li .
Advances in the treatment of BRAF V600-mutant non-small cell lung cancer
[J]. China Oncology, 2021, 31(12): 1145-1152.
|
[7] |
HE Xi, JIAO Xiaodong, ZANG Yuansheng.
Clinical research progress of tumor mutational burden in EGFR-mutant advanced non-small cell lung cancer
[J]. China Oncology, 2021, 31(1): 69-75.
|
[8] |
ZHANG Xin , ZHOU Cheng , ZHOU Kaiqian , BAI Qianming , JIANG Dongxian , SUJIE Akesu , HOU Yingyong , WANG Zheng , JI Yuan .
MET gene amplification and its prognostic role in sarcomatoid hepatocellular carcinoma
[J]. China Oncology, 2020, 30(9): 641-649.
|
[9] |
XU Shanshan , SONG Qinqin , WU Hongjiao , FU Ning , CHE Lingyu , JIN Min , LIU Chong , HAN Sugui , ZHANG Xuemei , ZHANG Zhi .
Genetic variation in membrane cofactor protein CD46 rs1970530 affects the risk of hepatocellular carcinoma
[J]. China Oncology, 2020, 30(9): 656-660.
|
[10] |
CHEN Xinning , WANG Beili , GUO Wei .
Impact of clonal hematopoiesis on the detection of somatic mutation
[J]. China Oncology, 2020, 30(9): 707-711.
|
[11] |
ZHU Lihua , NI Tingting , FAN Xingwen , WU Kailiang .
Comparison of prognostic scoring systems in patients with EGFR-mutant lung cancer and brain metastases
[J]. China Oncology, 2020, 30(8): 605-610.
|
[12] |
OUYANG Xiaochun , ZOU Yeqing , LI Yumei , DING Xiaobing .
ARHGAP4 promotes growth of hepatocellular carcinoma cells by regulating HK2 expression
[J]. China Oncology, 2020, 30(7): 481-487.
|
[13] |
PI Sidie, ZHENG Xiaochuan, MAO Binli, CUI Jing, HU Yuan.
SAMHD1 inhibits the proliferation of hepatocellular carcinoma by regulating the expression of p27
[J]. China Oncology, 2020, 30(7): 489-496.
|
[14] |
DONG Baolong , HE Yu , CHEN Shiyong , WU Biao , GAO Peng , YANG Xiaojun .
Expression of KIF21B in hepatocellular carcinoma and its clinical significance
[J]. China Oncology, 2020, 30(5): 355-361.
|
[15] |
MENG Qiuhua, TIAN Jing, QIN Yan, MENG Qiuxiao, DONG Min.
The mechanism of protein tyrosine phosphatase receptor type delta affecting expression of PD-L1 in hepatocellular carcinoma via STAT3 pathway
[J]. China Oncology, 2020, 30(4): 261-267.
|